Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Farcet

Showing results (101-110 of 109) with videos related to

Pageof 11
Sort By:
You have reached the last page of results.This site can display upto 109 results.
Cancer|September 1, 1983
Early response to chemotherapy as a prognostic factor in Hodgkin's diseaseM Kuentz, F Reyes, B Brun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantationE Leroy, C F Calvo, M Divine, et al.
Journal of Immunological Methods|August 1, 2000
Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacityH Rouard, A Léon, B Klonjkowski, et al.
Gut|October 30, 2007
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomasS Le Gouvello, S Bastuji-Garin, N Aloulou, et al.
Experimental Hematology|July 2, 1999
Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomasL Chaperot, M H Delfau-Larue, M C Jacob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution studyK Belhadj, M-H Delfau-Larue, T Elgnaoui, et al.
Leukemia|May 14, 2009
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesA Carbonnelle-Puscian, C Copie-Bergman, M Baia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2007
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphomaA Plonquet, C Haioun, J-P Jais, et al.
Journal of Neuroimmunology|January 5, 2002
Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndromeA Plonquet, R K Gherardi, A Créange, et al.
Pageof 11

Showing results (101-110 of 109) with videos related to

Sort By:
Pageof 11
You have reached the last page of results.This site can display upto 109 results.
Cancer|September 1, 1983
Early response to chemotherapy as a prognostic factor in Hodgkin's diseaseM Kuentz, F Reyes, B Brun, et al.
Journal of Immunology (Baltimore, Md. : 1950)|October 1, 1986
Persistence of T8+/HNK-1+ suppressor lymphocytes in the blood of long-term surviving patients after allogeneic bone marrow transplantationE Leroy, C F Calvo, M Divine, et al.
Journal of Immunological Methods|August 1, 2000
Adenoviral transduction of human 'clinical grade' immature dendritic cells enhances costimulatory molecule expression and T-cell stimulatory capacityH Rouard, A Léon, B Klonjkowski, et al.
Gut|October 30, 2007
High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomasS Le Gouvello, S Bastuji-Garin, N Aloulou, et al.
Experimental Hematology|July 2, 1999
Differentiation of antitumor-specific cytotoxic T lymphocytes from autologous tumor infiltrating lymphocytes in non-Hodgkin's lymphomasL Chaperot, M H Delfau-Larue, M C Jacob, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
Efficiency of in vivo purging with rituximab prior to autologous peripheral blood progenitor cell transplantation in B-cell non-Hodgkin's lymphoma: a single institution studyK Belhadj, M-H Delfau-Larue, T Elgnaoui, et al.
Leukemia|May 14, 2009
The novel immunosuppressive enzyme IL4I1 is expressed by neoplastic cells of several B-cell lymphomas and by tumor-associated macrophagesA Carbonnelle-Puscian, C Copie-Bergman, M Baia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 15, 2007
Peripheral blood natural killer cell count is associated with clinical outcome in patients with aaIPI 2-3 diffuse large B-cell lymphomaA Plonquet, C Haioun, J-P Jais, et al.
Journal of Neuroimmunology|January 5, 2002
Oligoclonal T-cells in blood and target tissues of patients with anti-Hu syndromeA Plonquet, R K Gherardi, A Créange, et al.
Pageof 11